HSIC vs MCK vs VEEV Stock Comparison

Henry Schein, Mckesson and Veeva Systems Prices as of Oct 23, 2026 Peers: Industry group
HSIC Henry Schein Inc
$84.96 -0.1% 1M +33.6% 1Y
Market cap
$9.59B
P/E
23.8x
Revenue (TTM)
$13.60B
Div. yield
–
Drug Distribution Healthcare
4 wins
MCK Mckesson Corp
$1,001.01 +13.6% 1M +26.2% 1Y
Market cap
$117.56B
P/E
25.6x
Revenue (TTM)
$410.98B
Div. yield
0.00%
Drug Distribution Healthcare
4 wins
VEEV Veeva Systems Inc
$322.91 +19.2% 1M +10.8% 1Y
Market cap
$51.67B
P/E
50.9x
Revenue (TTM)
$3.46B
Div. yield
–
Healthcare IT Technology
3 wins

Head to Head

11 decided of 12

Mckesson leads on 4 of the 12 questions below (Mckesson 4, Henry Schein 4, Veeva Systems 3). Which ones matter depends on what you are buying for; a cheap multiple and slow growth often come together.

QuestionHSICMCKVEEVLeader
Larger companyMarket capitalisation $9.59B $117.56B $51.67B MCK
Cheaper on earningsLower P/E, profitable companies only 23.8x 25.6x 50.9x HSIC
Cheaper on forward earningsLower price / next fiscal year consensus EPS 14.8x 21.2x 36.0x HSIC
Faster revenue growthRevenue growth, trailing twelve months +6.5% +8.8% +16.5% VEEV
More profitableNet margin, trailing twelve months 3.0% 1.1% 29.3% VEEV
Better return on capitalReturn on invested capital 7.1% 107.9% — MCK
Less leveragedLower net debt / EBITDA 3.3x 0.6x — MCK
Higher dividend yieldTrailing dividend yield 0.00% 0.00% 0.00% –
Better 1-year returnPrice return, last 12 months +33.6% +26.2% +10.8% HSIC
Better 5-year returnAnnualised price return, 5 years +1.2%/yr +36.8%/yr +0.1%/yr MCK
Less volatileAnnualised volatility, 1 year 25.6% 30.6% 42.8% HSIC
Higher overall scoreMean of the five percentile scores vs peers 55/100 60/100 68/100 VEEV

Percentile Scorecard

HSICMCKVEEV

Each axis is the mean percentile of its metrics against the company's industry group. 100 is the best in the group, 50 the middle.

Scores by Axis

AxisHSICMCKVEEV
Valuation 33 #17 of 25 54 #12 of 25 35 #59 of 90
Growth 39 #15 of 24 65 #9 of 24 74 #22 of 82
Profitability 83 #5 of 24 65 #9 of 24 87 #11 of 77
Financial Health 20 #21 of 26 52 #13 of 26 95 #6 of 96
Shareholder Returns 100 #1 of 17 63 #7 of 17 49 #28 of 54
Overall 55 60 68
  • HSIC ranked among 27 companies in Healthcare Payers and Distributors
  • MCK ranked among 27 companies in Healthcare Payers and Distributors
  • VEEV ranked among 99 companies in Vertical Software

Price Performance

Price return, split-adjusted, before dividends. Click a name to hide or show it.

Returns

PeriodHSICMCKVEEVSPY
1 month -0.1%+13.6%+19.2% -1.0%
3 months -0.6%+19.1%+73.3% +2.9%
6 months +9.6%+20.9%+100.4% +6.4%
Year to date +12.4%+22.0%+44.7% +11.4%
1 year +33.6%+26.2%+10.8% +13.1%
3 years +26.2%+121.4%+63.8% +79.4%
3 years, per year +8.1%+30.4%+17.9% +21.5%
5 years +6.3%+378.7%+0.7% +67.7%
5 years, per year +1.2%+36.8%+0.1% +10.9%
10 years +42.0%+521.6%+732.0% +255.2%
10 years, per year +3.6%+20.1%+23.6% +13.5%

Risk

MeasureHSICMCKVEEVSPY
Volatility, 1Y 25.6%30.6%42.8% 12.7%
Downside volatility, 1Y 24.1%27.4%40.4% 12.7%
Beta vs S&P 500, 1Y 0.46-0.250.58 1.00
Return / volatility, 1Y 1.310.860.25 1.03
Max drawdown, 5Y -32.7%-27.2%-53.2% -25.4%
From 52-week high -6.5%-2.8%0.0% -2.5%
52-week high $90.86$1,030.18$322.91 $779.14
52-week low $62.32$725.17$151.43 $631.97

Valuation History

Weekly multiples on trailing twelve-month fundamentals. Negative or extreme readings (a loss year, a collapsed denominator) are left out so the chart stays readable.

MultipleHSICMCKVEEV
P/E now vs peer median 23.9xmedian 24.5x 25.9xmedian 24.5x 51.7xmedian 42.7x
P/S now vs peer median 0.7xmedian 0.3x 0.3xmedian 0.3x 15.1xmedian 2.7x
EV/EBITDA now vs peer median 12.7xmedian 14.4x 16.7xmedian 14.4x 41.2xmedian 19.0x
P/FCF now vs peer median 16.7xmedian 15.8x 18.2xmedian 15.8x 31.4xmedian 19.6x
P/B now vs peer median 2.5xmedian 2.5x -27.5xmedian 2.5x 7.0xmedian 1.8x
PEG now vs peer median 50.09median 1.35 2.16median 1.35 2.25median 1.75

Financial History

Reported figures by fiscal period, placed on the calendar year (or quarter) each period ended in, so companies with different fiscal years line up.

Trailing twelve monthsHSICMCKVEEV
Revenue $13.60B $410.98B $3.46B
Gross profit $4.26B $14.96B $2.59B
Operating income $680.00M $6.50B $1.03B
Net income $426.00M $5.30B $1.01B
Free cash flow $569.00M $6.42B $1.67B
R&D – – $821.92M
EPS (diluted) $3.52 $38.52 $6.15
Cash & equivalents – $5.16B $1.81B
Total debt $3.46B $9.73B –
Shares (diluted) 114.39M 119.20M 165.06M
Enterprise value $9.43B $101.45B $23.91B

All Metrics

58 metrics · best in bold

Bold marks the best reading: the lowest positive value for multiples, leverage and payout, the highest for everything else. The bar under each value is its percentile against that company's own peers. Hover a value for its rank and the peer median.

Valuation

12 metrics
MetricHSICMCKVEEV
P/E 23.9x 25.9x 51.7x
P/FCF 16.7x 18.2x 31.4x
P/Operating cash flow 13.6x 17.0x 31.4x
P/S 0.7x 0.3x 15.1x
P/B 2.5x -27.5x 7.0x
P/Tangible book 3.3x -14.1x 7.1x
EV/EBITDA 12.7x 16.7x 41.2x
EV/EBIT 18.8x 18.7x 43.5x
EV/Revenue 0.9x 0.3x 13.0x
EV/FCF 22.5x 18.9x 27.0x
EV/Operating cash flow 18.3x 17.7x 27.0x
PEG (3Y EPS CAGR) 50.09 2.16 2.25

Growth

14 metrics
MetricHSICMCKVEEV
Revenue growth (1Y) 6.5% 8.8% 16.5%
Revenue CAGR (3Y) 2.6% 13.1% 15.7%
Gross profit growth (1Y) 6.4% 11.2% 15.5%
Gross profit CAGR (3Y) 3.4% 6.6% 18.0%
Operating income growth (1Y) 6.6% 46.6% 29.5%
Operating income CAGR (3Y) 1.1% 13.5% 37.8%
Net income growth (1Y) 6.0% 58.1% 25.3%
Net income CAGR (3Y) -4.5% 10.7% 23.4%
EPS growth (1Y) 11.1% 52.8% 27.3%
EPS CAGR (3Y) 0.5% 12.0% 22.9%
Operating cash flow growth (1Y) 36.7% 4.7% 23.4%
Operating cash flow CAGR (3Y) 2.3% 10.7% 19.5%
Free cash flow growth (1Y) 50.1% 6.8% 23.4%
Free cash flow CAGR (3Y) 2.3% 11.3% 19.5%

Profitability

14 metrics
MetricHSICMCKVEEV
Gross margin 31.3% 3.6% 75.0%
EBITDA margin 7.4% 1.8% 31.6%
Operating margin 5.0% 1.6% 29.9%
Pretax margin 4.1% 1.6% 38.4%
Net margin 3.0% 1.1% 29.3%
FCF margin 4.2% 1.6% 48.2%
Operating cash flow margin 5.1% 1.7% 48.2%
Return on equity 11.0% – 13.8%
Return on assets 3.8% 6.2% 11.2%
Return on invested capital 7.1% 107.9% –
Return on capital employed 8.7% 43.4% 13.5%
Asset turnover 1.2x 4.8x 0.4x
Cash conversion (OCF / net income) 1.6x 1.3x 1.6x
Stock comp / revenue 0.3% – 14.3%

Financial Health

11 metrics
MetricHSICMCKVEEV
Debt / assets 30.4% 11.0% –
Debt / equity 0.9x -2.3x –
Net debt / EBITDA 3.3x 0.6x –
Debt / FCF 6.1x 1.5x –
Liabilities / assets 66.5% 104.8% 18.0%
Equity / assets 33.5% -4.8% 82.0%
Interest coverage 4.3x 23.6x –
Current ratio 1.3x 0.9x 5.5x
Quick ratio 0.6x 0.5x 5.4x
Cash ratio 0.0x 0.1x 5.0x
Altman Z-score 2.66 5.91 21.63

Shareholder Returns

7 metrics
MetricHSICMCKVEEV
Dividend yield – 0.3% –
Net buyback yield 7.6% 5.7% 0.7%
Shareholder yield 7.6% 6.0% 0.7%
Payout ratio (earnings) – 7.4% –
Payout ratio (FCF) – 6.1% –
Dividend growth (1Y) – 11.3% –
Dividend CAGR (3Y) – 10.0% –

Analyst Estimates

Solid lines are reported fiscal-year results; dashed lines are the consensus for the years ahead. Hover a year for the analysts' high and low, and how each result compared with its estimate.

ConsensusHSICMCKVEEV
Forward P/E 14.8xFY2026 21.2xFY2026 36.0xFY2026
EPS, next fiscal year $5.75FY2026 $47.14FY2026 $8.97FY2026
EPS growth, next FY +15.7%FY2026 +20.5%FY2026 +10.7%FY2026
EPS growth, the year after +8.2% +11.1% +16.8%
Revenue, next fiscal year $13.38BFY2026 $444.51BFY2026 $3.60BFY2026
Revenue growth, next FY +1.5%FY2026 +10.2%FY2026 +12.5%FY2026
Revenue growth, the year after +4.9% +1.4% +17.3%

Institutional Ownership

13F filings, quarter ended Jun 30, 2026
HoldersHSICMCKVEEV
Held by institutions 100.0% 89.1% 88.8%
Institutions holding 564 2,007 1,056
Change in shares held, QoQ +2.1% -0.7% +5.7%
Institutions buying 245 879 586
Institutions selling 216 791 358
Buyers to sellers 1.13 1.11 1.64

Return Correlation

Daily returns, last 12 months

1.00 means two stocks move in lockstep, 0 that they move independently. Pairs below about 0.5 diversify each other.

HSICMCKVEEV
HSIC 1.00 0.30 0.12
MCK 0.30 1.00 -0.04
VEEV 0.12 -0.04 1.00

Add a Peer

Largest companies in the same industry

Related Comparisons

Frequently Asked Questions

Which is bigger, HSIC, MCK and VEEV?

Mckesson (MCK) is the largest by market capitalisation: Henry Schein (HSIC) $9.59B, Mckesson (MCK) $117.56B, Veeva Systems (VEEV) $51.67B.

Which stock is cheaper, HSIC, MCK and VEEV?

Henry Schein (HSIC) trades on the lowest price-to-earnings ratio (Henry Schein (HSIC) 23.8x, Mckesson (MCK) 25.6x, Veeva Systems (VEEV) 50.9x). On next year's consensus earnings, Henry Schein (HSIC) is cheapest (Henry Schein (HSIC) 14.8x, Mckesson (MCK) 21.2x, Veeva Systems (VEEV) 36.0x). A lower multiple can reflect slower expected growth, so read it next to the growth figures.

Which company is growing faster?

Veeva Systems (VEEV) grew revenue fastest over the trailing twelve months: Henry Schein (HSIC) +6.5%, Mckesson (MCK) +8.8%, Veeva Systems (VEEV) +16.5%.

Which company is more profitable?

Veeva Systems (VEEV) has the highest net margin (Henry Schein (HSIC) 3.0%, Mckesson (MCK) 1.1%, Veeva Systems (VEEV) 29.3%). On return on invested capital, Mckesson (MCK) leads (Henry Schein (HSIC) 7.1%, Mckesson (MCK) 107.9%).

Which stock has performed better?

Over the past year Henry Schein (HSIC) returned the most: Henry Schein (HSIC) +33.6%, Mckesson (MCK) +26.2%, Veeva Systems (VEEV) +10.8%. Over five years, Mckesson (MCK) compounded fastest (Henry Schein (HSIC) +1.2%/yr, Mckesson (MCK) +36.8%/yr, Veeva Systems (VEEV) +0.1%/yr). Returns are price only, before dividends.

Which pays a higher dividend?

Only one of these companies pays a dividend: Henry Schein (HSIC) 0.00%, Mckesson (MCK) 0.00%, Veeva Systems (VEEV) 0.00%. Henry Schein (HSIC) and Veeva Systems (VEEV) pays no regular dividend.

Which stock is riskier?

By one-year price volatility, Henry Schein (HSIC) has been the steadiest (Henry Schein (HSIC) 25.6%, Mckesson (MCK) 30.6%, Veeva Systems (VEEV) 42.8%). Volatility measures how widely the price swings, not the risk of the business.

Which is the better stock, HSIC, MCK and VEEV?

There is no single answer; it depends on what you are buying for. On the 12 head-to-head measures on this page, Mckesson (MCK) leads on 4. Business Quant does not give investment advice; use the comparison as a starting point for your own research.

Data from SEC filings, exchange prices and consensus estimates, via Business Quant. Percentile scores compare each company with its own peer group, so two companies' scores are each relative to different peers unless you rank against the whole market. Price returns exclude dividends. Nothing on this page is investment advice.